Home »
GENEVA (Reuters) – The World Health Organization (WHO) approved a COVID-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing’s push for a big role in inoculating the world. The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the […]
Read more
(Reuters) – Europe’s medicines regulator said on Tuesday it has started a real-time review of Sinovac’s COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus. Data on the vaccine, COVID-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed up potential […]
Read more
As Americans travel again and airlines begin filling their planes to capacity, the CDC says blocking the middle seats on commercial airliners could reduce the transmission of COVID-19 by 23% to 57%. Researchers studied laboratory models of single-aisle and double-aisle aircraft using aerosol dispersion as a surrogate for the coronavirus, according to findings reported Wednesday in the CDC’s Morbidity and […]
Read more
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. After receiving reports of a rare blood clot in people receiving the Johnson & Johnson COVID-19 vaccine, the FDA and the CDC have recommended a pause in the use of the vaccine, pending further investigation. Here is what you need to know: Why was the pause […]
Read more
BERLIN (Reuters) – Germany’s vaccine commission, known as STIKO, recommended on Thursday that people under 60-years old who have had a first shot of AstraZeneca’s COVID-19 vaccine should receive a different product for their second dose. Earlier in the week, Germany said only people aged 60 and over should be administered the AstraZeneca vaccine due to the rare but severe […]
Read more
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two reports support the safety and immunogenicity of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal diseases (RMDs) and represent the first available data on such patients. In an observational cohort study published in Annals of the Rheumatic Diseases, Caoilfhionn M. Connolly, MD, of Johns Hopkins […]
Read more
BUDAPEST (Reuters) – Hungary’s oldest general practitioner at the age of 97 receives patients every day and administers COVID-19 vaccines with an unwavering devotion to his profession. Istvan Kormendi says he was inspired from his early childhood by the example of his father, who was also a GP. He still lives in the high-ceilinged old apartment on the Buda side […]
Read more
MILAN (Reuters) – Lombardy, the Italian region worst-hit by COVID-19, is going to adopt an algorithm devised by scientists to help get its faltering vaccination drive back on track by deciding who should get the jab first. A team at Milan’s Bicocca University developed the algorithm to put an end to regional disparities in vaccination policy, cutting through disputes among […]
Read more
MILAN (Reuters) – Lombardy, the Italian region worst-hit by COVID-19, is going to adopt an algorithm devised by scientists to help get its faltering vaccination drive back on track by deciding who should get the jab first. A team at Milan’s Bicocca University developed the algorithm to put an end to regional disparities in vaccination policy, cutting through disputes among […]
Read more
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The United States probably won’t reach herd immunity until children are vaccinated, Anthony Fauci, MD, said. “We don’t really know what that magical point of herd immunity is, but we do know that if we get the overwhelming population vaccinated, we’re going to be in good […]
Read more